Thibault Frisch
Research Subjects
Thibault Frisch has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- André Mateus
Umeå University
1 shared publication - Anjeela Bhetwal
Department of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, Nepal
1 shared publication - Erik Holmqvist
Department of Cell and Molecular Biology, Biomedical Centre, Uppsala University, Uppsala, Sweden
1 shared publication - Esther Lehmann
Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark
1 shared publication - Freja C. Mikkelsen1 shared publication
- Hanne Ingmer
Department of Veterinary and Animal Sciences Faculty of Health and Medical Sciences University of Copenhagen Frederiksberg Denmark
1 shared publication
Latest Publications
- Open Access
Phage resistance impacts antibiotic susceptibility and virulence in Staphylococcus aureus
As antibiotic resistance continues to rise worldwide, phage therapy offers a promising solution by harnessing viruses that infect and kill bacteria. However, phage-resistance may develop, compromising therapy. Phage-resistance has primarily been linked to changes in major phage receptors that for the human pathogen Staphylococcus aureus are the cell-wall linked wall teichoic acids (WTA). To identify additional factors contributing to phage-resistance, S. aureus was evolved under selective pressure from lytic phages, including candidates from therapeutic phage cocktails, to obtain resistant clones. A third of the phage-resistant clones acquired mutations associated with cell-wall changes previously linked with phage resistance, namely in femA , involved in peptidoglycan crossbridge formation, and tagO , encoding the initiator of the WTA biosynthesis. The remaining clones had mutations in pathways not previously associated with phage-resistance, including nucleoside catabolism ( deoC1 ), polyamine import ( potAB ) and DNA/RNA replication ( cshA, ligA ), suggesting that phage-resistance may be associated with phage-driven host takeover. Antibiotic susceptibility and virulence were diversely affected by the mutations; mutations in tagO increased β-lactams sensitivity and attenuated virulence, whereas mutations in femA / ligA or cshA increased staphylococcal virulence in Galleria mellonella . This work demonstrates the involvement of several novel bacterial pathways in phage resistance, highlighting the complexity behind phage-bacterial interactions.
Open AccessPhage resistance impacts antibiotic susceptibility and virulence in Staphylococcus aureus
As antibiotic resistance continues to rise worldwide, phage therapy offers a promising solution by harnessing viruses that infect and kill bacteria. However, phage-resistance may develop, compromising therapy. Phage-resistance has primarily been linked to changes in major phage receptors that for the human pathogen Staphylococcus aureus are the cell-wall linked wall teichoic acids (WTA). To identify additional factors contributing to phage-resistance, S. aureus was evolved under selective pressure from lytic phages, including candidates from therapeutic phage cocktails, to obtain resistant clones. A third of the phage-resistant clones acquired mutations associated with cell-wall changes previously linked with phage resistance, namely in femA , involved in peptidoglycan crossbridge formation, and tagO , encoding the initiator of the WTA biosynthesis. The remaining clones had mutations in pathways not previously associated with phage-resistance, including nucleoside catabolism ( deoC1 ), polyamine import ( potAB ) and DNA/RNA replication ( cshA, ligA ), suggesting that phage-resistance may be associated with phage-driven host takeover. Antibiotic susceptibility and virulence were diversely affected by the mutations; mutations in tagO increased β-lactams sensitivity and attenuated virulence, whereas mutations in femA / ligA or cshA increased staphylococcal virulence in Galleria mellonella . This work demonstrates the involvement of several novel bacterial pathways in phage resistance, highlighting the complexity behind phage-bacterial interactions.
- Open Access
The pcnB gene sustains Shigella flexneri virulence
The enteropathogen Shigella flexneri employs a Type Three Secretion System (T3SS) to colonize intestinal epithelial cells. Genes encoding the T3SS are located on a large IncFII virulence plasmid, pINV. T3SS expression comes at the expense of slowed Shigella growth and is therefore strictly controlled by both transcriptional and post-transcriptional mechanisms. Following up on a recent genome-wide screen, we here show that the chromosomal gene pcnB, encoding the poly-A polymerase I (PAP-I), slows Shigella growth at 37°C, while at the same time promotes early colonization of a human epithelial enteroid model. Proteomic profiling revealed that pcnB drives global increase of the Shigella T3SS virulence program. Accordingly, pcnB sustains pINV replication to a level optimal for Shigella virulence. This is achieved through increased degradation of the antisense RNA CopA, involved in plasmid replication control. The pcnB effect on pINV replication was found to also ensure longer-term intraepithelial expansion of Shigella following human intestinal epithelium invasion. Our findings exemplify how an optimal pINV level is necessary for the execution of Shigella ’s infection cycle. AUTHOR SUMMARY: Bacterial infections represent a major global threat. Understanding the genetic determinants promoting infections is crucial to overcome this threat. Shigella is an intracellular bacterial pathogen that invades and disseminates in the intestinal epithelium, causing bacillary dysentery in humans. Shigella’s ability to cause disease relies on the delivery of effector proteins into the host cells through an injection machinery, with most of the genes involved in this process located on a large virulence plasmid. Here we show that the chromosomal gene pcnB sustains an optimal virulence plasmid level. This is crucial for Shigella to maximize virulence protein expression and thereby efficiently invade, replicate and spread within the intestinal epithelium.
Open AccessThe pcnB gene sustains Shigella flexneri virulence
The enteropathogen Shigella flexneri employs a Type Three Secretion System (T3SS) to colonize intestinal epithelial cells. Genes encoding the T3SS are located on a large IncFII virulence plasmid, pINV. T3SS expression comes at the expense of slowed Shigella growth and is therefore strictly controlled by both transcriptional and post-transcriptional mechanisms. Following up on a recent genome-wide screen, we here show that the chromosomal gene pcnB, encoding the poly-A polymerase I (PAP-I), slows Shigella growth at 37°C, while at the same time promotes early colonization of a human epithelial enteroid model. Proteomic profiling revealed that pcnB drives global increase of the Shigella T3SS virulence program. Accordingly, pcnB sustains pINV replication to a level optimal for Shigella virulence. This is achieved through increased degradation of the antisense RNA CopA, involved in plasmid replication control. The pcnB effect on pINV replication was found to also ensure longer-term intraepithelial expansion of Shigella following human intestinal epithelium invasion. Our findings exemplify how an optimal pINV level is necessary for the execution of Shigella ’s infection cycle. AUTHOR SUMMARY: Bacterial infections represent a major global threat. Understanding the genetic determinants promoting infections is crucial to overcome this threat. Shigella is an intracellular bacterial pathogen that invades and disseminates in the intestinal epithelium, causing bacillary dysentery in humans. Shigella’s ability to cause disease relies on the delivery of effector proteins into the host cells through an injection machinery, with most of the genes involved in this process located on a large virulence plasmid. Here we show that the chromosomal gene pcnB sustains an optimal virulence plasmid level. This is crucial for Shigella to maximize virulence protein expression and thereby efficiently invade, replicate and spread within the intestinal epithelium.